SCHEMBL3662514

SCHEMBL3662514

[c]1ncccc1-c1ccc(N2CCOCC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.48
MAPT P10636 7/20 0.48
NPC1 O15118 5/20 0.48
RAB9A P51151 5/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
GAA P10253 2/20 0.48
ALDH1A1 P00352 7/20 0.45
HTT P42858 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
CYP1A2 P05177 1/20 0.45
LMNA P02545 3/20 0.44
CNR2 P34972 1/20 0.43
HPGD P15428 4/20 0.41
TP53 P04637 3/20 0.41
ALOX15 P16050 3/20 0.41
HSD17B10 Q99714 3/20 0.41
MAPK1 P28482 2/20 0.40
PDE3B Q13370 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL441105 0.75 LMNA (0.42) KDM4EMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL9093746 0.71 LMNA (0.71) KDM4EMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5133066 0.70 LMNA (0.72) KDM4EMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL2185035 0.70 MAPT (0.46) KDM4EMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL19439 0.69 NOTUM (0.39) NPC1RAB9ASMN1; SMN2ALDH1A1MEN1
SCHEMBL7014996 0.69 MAPT (0.51) KDM4EMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL2412002 0.69 NOTUM (0.39) KDM4ENPC1RAB9AL3MBTL1GAA
SCHEMBL1515426 0.69 NISCH (0.38) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL4590846 0.69 MAPK14 (0.35) MAPTNPC1RAB9AALDH1A1KMT2A
SCHEMBL5797199 0.68 MAPT (0.43) KDM4EMAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231602-A1 GAMMA SECRETASE MODULATORS Amgen, Inc (US) 2010-09-29 EP disclosed
WO-2009075874-A1 GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-06-18 WO disclosed